Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 16,400,000 | 17,276,000 | 15,806,000 | 15,529,000 | 15,624,000 |
| Cost of Goods | 5,551,000 | 3,855,000 | 3,557,000 | 3,419,000 | 3,828,000 |
| Gross Profit | 10,849,000 | 13,421,000 | 12,249,000 | 12,110,000 | 11,796,000 |
| Operating Expenses | 6,785,000 | 6,867,000 | 6,697,000 | 6,173,000 | 7,447,000 |
| Operating Income | 4,064,000 | 6,554,000 | 5,552,000 | 5,937,000 | 4,349,000 |
| Other Income | -644,000 | 191,000 | -553,000 | -34,000 | -179,000 |
| Pre-tax Income | 3,420,000 | 6,745,000 | 4,999,000 | 5,903,000 | 4,170,000 |
| Income Tax | 457,000 | 958,000 | 571,000 | 818,000 | 426,000 |
| Net Income Continuous | 2,963,000 | 5,787,000 | 4,428,000 | 5,085,000 | 3,744,000 |
| Minority Interests | N/A | 2,000 | 1,000 | 6,000 | 1,000 |
| Net Income | $2,963,000 | $5,785,000 | $4,427,000 | $5,079,000 | $3,743,000 |
| EPS Basic Total Ops | 1.21 | 2.32 | 1.76 | 2.01 | 1.48 |
| EPS Basic Continuous Ops | 1.20 | 2.32 | 1.76 | 2.02 | 1.48 |
| EPS Diluted Total Ops | 1.19 | 2.32 | 1.76 | 2.01 | 1.49 |
| EPS Diluted Continuous Ops | 1.20 | 2.32 | 1.76 | 2.01 | 1.48 |
| EPS Diluted Before Non-Recurring Items | 2.04 | 2.58 | 2.13 | 2.22 | 1.72 |
| EBITDA(a) | $6,530,000 | $7,708,000 | $6,671,000 | $7,036,000 | $5,546,000 |